Turning Point Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, March 04, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
SAN DIEGO, March 04, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
CINCINNATI, March 04, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of…
Data Analysis Supports Use of Predictive Enrichment Markers in Phase 2b OraGrowtH210 Trial AUSTIN, Texas,…
Company to Host Conference Call, March 11, 2021, at 4:30 p.m. ET LOS ANGELES, March…
MONTREAL, March 04, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical…
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX…
Conference Call to be Held at 4:30pm Eastern Time ROCKAWAY, N.J., March 04, 2021 (GLOBE…
NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE: DXR), the global leader…
BOSTON and JERUSALEM, March 04, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a…
Study of porcine model of blast injury and haemorrhagic shock underway with USAISR as part…